Vaccine - EpiLinks

Cold chain and logistics for COVID-19 vaccine in Bosnia and Herzegovina

by arnaud debuyzer | 25 May, 2022 | Logistics and health systems, Operational research and evaluation, Outbreak response, Strategic and operational guidelines and tools, Vaccine

Strengthening logistics and cold chain in support of health authorities for the deployment of COVID-19 vaccine. The deployment of the Covid-19 vaccine poses unprecedented logistical challenges for health authorities. The large quantity of vaccine, its special storage...

WORKSHOP ON DENGUE VACCINATION IN THE CONTEXT OF A TEST-AND-VACCINATE STRATEGY IN BRAZIL

by arnaud debuyzer | 25 May, 2022 | Epidemiology and biology, Strategic and operational guidelines and tools, Vaccine

Regional brainstorming for the development of guidelines for the implementation of the dengue vaccine. The state of Paraná in Brazil has conducted community-based campaigns for dengue vaccination during 2016-2018. Following the new Sanofi Pasteur product label and...

EXPERT MEETING FOR DENGUE VACCINE IMPLEMENTATION IN LATIN AMERICA

by arnaud debuyzer | 25 May, 2022 | Epidemiology and biology, Scientific communication, Vaccine

For a better understanding of the new recommendations for the dengue vaccine implementation. The 6th Expert meeting on dengue vaccine implementation in Latin America was held June 22 and 23 2018 in Lima, Peru. The meeting convened a permanent group of Latin America...

TECHNICAL SUPPORT FOR THE INTRODUCTION OF ROTAVIRUS VACCINE IN THE DEMOCRATIC REPUBLIC OF CONGO

by arnaud debuyzer | 25 May, 2022 | Logistics and health systems, Operational research and evaluation, Strategic and operational guidelines and tools, Vaccine

A logistical feasibility assessment. The rotavirus vaccine prevents gastrointestinal infections, which are common causes of fatal diarrheal diseases in children. The DRC has decided to offer this vaccine to all children in the country. EpiLinks has provided technical...

TECHNICAL SUPPORT TO DENGUE VACCINE IMPLEMENTATION: INFORMATION FOR DECISION-MAKING

by arnaud debuyzer | 25 May, 2022 | Epidemiology and biology, Scientific communication, Strategic and operational guidelines and tools, Vaccine

Since December 2015, dengue is a vaccine-preventable disease. What are the key factors to consider for vaccine introduction. The CYD-TDV vaccine (commercial name Dengvaxia®) is a dengue tetravalent vaccine (live attenuated), that has been licensed for the prevention...

EXPERT MEETING ON RAPID DIAGNOSTIC TESTS AND IMPLEMENTATION STRATEGIES FOR THE DENGUE VACCINE